Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up--a comparison.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Liver

• Publication date

  2008-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1600-0676.1989.TB00388.XPMID 2496281
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome.

  2008cited by this paper
• Post-transfusional vs. sporadic non-A, non-B chronic hepatitis. A clinico-pathological and evolutive study.

  2008cited by this paper
• Non-A, non-B hepatitis after open-heart surgery in Stockholm: declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virus.

  1988cited by this paper
• Chronic Non-A, Non-B Hepatitis: A Long-Term Follow-up Study in 49 Patients

  1987cited by this paper
• Chronic liver disease following community-acquired non-A, non-B hepatitis.

  1986cited by this paper
• Non-A, Non-B Hepatitis: Evolving Epidemiologic and Clinical Perspective

  1986cited by this paper
• Non-A, non-B hepatitis after intravenous gammaglobulin.

  1986cited by this paper
• Epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis center. II: Clinical observations and a four-year follow-up of patients

  1985cited by this paper
• Survival in chronic hepatitis B. An analysis of 379 patients.

  1984cited by this paper
• Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.

  1982cited by this paper
• Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis.

  1981cited by this paper
• Acute viral hepatitis, types A, B and non-A, non-B: a prospective study of the epidemiological, laboratory and prognostic aspects in 280 consecutive cases.

  1981cited by this paper
• Acute non-A, non-B hepatitis--clinical, epidemiological and histological characteristics.

  1980cited by this paper
• Clinical, epidemiological and prognostic aspects of hepatitis "non-A, non-B"--a comparison with hepatitis A and B.

  1979cited by this paper
• Chronic liver disease after acute non-A, non-B viral hepatitis.

  1979cited by this paper
• Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention.

  1977cited by this paper

• Detection of hepatitis C virus RNA in the liver by in situ hybridization.

  2008cites this paper
• Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.

  2008cites this paper
• Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment.

  2008cites this paper
• Long-term follow-up of chronic hepatitis non-A, non-B--with special reference to hepatitis C.

  2008cites this paper
• A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings

  2006cites this paper
• The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach.

  2004cites this paper
• Correlation of Genotypes and Route of Transmission with Histologic Activity and Disease Stage in Chronic Hepatitis C

  2004cites this paper
• Virus safety of human blood, plasma, and derived products.

  2002cites this paper
• Cost effectiveness of combination therapy for hepatitis C: a decision analytic model

  2002cites this paper
• Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

  2001cites this paper
• Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy

  2001cites this paper
• An Investigation of the Positive Rate of anti-HCV among Healthy Medi-screeners by RIA Method

  1999cites this paper
• Long‐term administration of interferon‐α in non‐responder patients with chronic hepatitis C: follow‐up of liver fibrosis over 5 years

  1999cites this paper
• Standards of treatment in chronic hepatitis C.

  1999cites this paper
• Changes in liver histopathology in women infected with hepatitis C through contaminated anti‐D immunoglobulin injections in Ireland

  1998cites this paper
• AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

  1998cites this paper
• Long-term outcome of chronic hepatitis C infection in a low-prevalence area.

  1998cites this paper
• Influence of the transmission route and disease duration in the histopathology of chronic hepatitis C: a study of 101 patients

  1998cites this paper
• Route of drug use and its implications for drug effect, risk of dependence and health consequences.

  1998cites this paper
• The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis.

  1997cites this paper
• [Genetic diversity of hepatitis C virus. Genotypes].

  1997cites this paper
• Hepatitis C virus--a pathogen for all people.

  1996cites this paper
• Clinical sequelae of hepatitis C acquired from injection drug use.

  1996cites this paper
• Histopathology of chronic hepatitis C in relation to epidemiological factors.

  1996cites this paper
• Patterns of progression

  1996cites this paper
• Hepatitis C viral infection in liver transplantation.

  1996cites this paper
• Immune-mediated liver damage in chronic hepatitis C.

  1995cites this paper
• Risks and Benefits of Interferon-α in the Treatment of Hepatitis

  1995cites this paper
• Risks and benefits of interferon-alpha in the treatment of hepatitis.

  1995cites this paper
• Chronic hepatitis C virus infection: clinical experience with 126 patients.

  1995cites this paper
• The clinical picture of acute and chronic hepatitis C.

  1994cites this paper
• Interferon therapy in chronic hepatitis C virus infection.

  1994cites this paper
• Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E viruses.

  1994cites this paper
• Rolling review–the pathogenesis, diagnosis and management of viral hepatitis

  1994cites this paper
• A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients.

  1994cites this paper
• Non-A, Non-B, Non-C, Non-E Acute Hepatitis: Does it Really Exist?

  1994cites this paper
• Interferon‐α2b therapy reduces liver fibrosis in chronic non‐A, non‐B hepatitis: A quantitative histological evaluation

  1993cites this paper
• Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test.

  1993cites this paper
• Chronic non-A, non-B hepatitis: role of hepatitis C virus.

  1993cites this paper
• The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug use

  1993cites this paper
• Histological difference between complete responders and nonresponders to interferon therapy of the livers of patients with chronic hepatitis C

  1993cites this paper
• Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C

  1993cites this paper
• Histological patterns of prolonged hepatitis C infection.

  1993cites this paper
• Assessment of Screening Tests for Transfusion-Associated Non-A Non-B Hepatitis

  1993cites this paper
• Diagnosis and treatment of the major hepatotropic viruses.

  1993cites this paper
• Viral markers in the treatment of hepatitis B and C.

  1993cites this paper
• Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides.

  1993cites this paper
• Historical patterns of prolonged hepatitis C infection

  1993cites this paper
• Prevalence of hepatitis C virus antibody in a liver transplantation population

  1992cites this paper
• Lymphocyte subsets and β2‐microglobulin expression in chronic hepatitis C/non‐A, non‐B. Effects of interferon‐alpha treatment

  1992cites this paper
• HBV and HCV infection in i.v. drug addicts; coinfection with HIV.

  1992cites this paper
• Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon.

  1992cites this paper
• Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis

  1992cites this paper
• Chronic Hepatitis and Cirrhosis

  1992cites this paper
• Incidence, prevalence, and clinical course of hepatitis C following liver transplantation.

  1992cites this paper
• Hepatitis NANB/C: klinisches Bild und Krankheitsverlauf

  1991cites this paper
• Chronic posttransfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus.

  1991cites this paper
• Blood-Borne Non-A, Non-B Hepatitis: Hepatitis C

  1991cites this paper
• Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation

  1991cites this paper
• Evaluation de la prévention des hépatites non A, non B post-transfusionnelles en France

  1991cites this paper
• Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection

  1990cites this paper
• Hepatitis C.

  1990cites this paper
• Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.

  1990cites this paper
• Recombinant α-interferon treatment of non-A, non-B (type C) hepatitis : review of studies and recommendations for treatment

  1990cites this paper
• Southwestern Internal Medicine Conference: Hepatitis C

  1990cites this paper
• [Testing for hepatitis C].

  1990cites this paper
• Non-A, non-B hepatitis and dentistry

  1990cites this paper
• A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.

  1989cites this paper